Regonat 40 Mg Regorafenib About
Grab the chance to experience brilliant cancer care with Regonat 40 mg Regorafenib, a featured antineoplastic ace, now available at a special rate. Engineered specifically for advanced cancer treatment, this oral tablet marries soaring therapeutic efficiency with trusted prescription strength. Each box holds 28 tablets, crafted for adults and suitable for conditions such as metastatic colorectal cancer, GIST, and HCC. Packaged in eye-catching white, blue, and red, and available in both English and Hindi, Regonat is your reliable treatment ally, sourced from India and designed to deliver results you can count on.
Strategic Application and Usage Areas
Regonat 40 mg Regorafenib is designed for use in the advanced management of cancers like metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). Administered orally, the tablet directly targets cancer cells, working as a kinase inhibitor to impede tumor growth. Its application surface is internal, making it a critical component in systemic cancer therapy. The recommended administration areas are strictly as prescribed by oncologists, and it is solely intended for adult patients.
Domestic Market Availability & Stock Policies
With stock ready for swift distribution, Regonat 40 mg Regorafenib is featured prominently across India's major domestic markets. Estimate arrival through our streamlined supply chains and reliable FOB ports. Our sample policy allows for smooth evaluation, ensuring clinics and medical professionals can access and assess the quality before bulk purchase. This pharmaceutical product stands out in the domestic mar with prompt delivery and robust support from India's leading manufacturers, suppliers, and traders.
FAQ's of Regonat 40 Mg Regorafenib:
Q: How should Regonat 40 mg Regorafenib be administered?
A: Regonat 40 mg tablets are taken orally and should only be used as directed by a qualified physician specializing in cancer treatment. Follow your physician's dosage and schedule strictly for optimal outcomes.
Q: What types of cancers is Regonat 40 mg indicated for?
A: Regonat is primarily indicated for adults with metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC). It acts as an antineoplastic agent to help manage advanced cancer conditions.
Q: When should the dosage of Regonat 40 mg be adjusted?
A: Dosage adjustments may be necessary based on your physician's assessment of treatment response and any potential side effects. Never alter the dosage yourself; always consult your healthcare professional before making changes.
Q: Where can I find information regarding the expiry and storage of Regonat?
A: Check the expiry date on the packaging and store the tablets below 30C in a dry place. Always keep the medication in its original box and out of reach of children.
Q: What is the process to obtain Regonat 40 mg Regorafenib?
A: Since it is a prescription medicine, you must consult an oncologist who can prescribe Regonat. It is available through authorized medical suppliers, with domestic stocks ready for immediate delivery.
Q: What benefits does Regonat offer over traditional cancer therapies?
A: Regonat provides targeted kinase inhibition, which can yield better management of tumor growth in advanced cancers, with a treatment protocol tailored specifically for adult patients under oncological supervision.